1. Home
  2. ALTI vs ESPR Comparison

ALTI vs ESPR Comparison

Compare ALTI & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALTI
  • ESPR
  • Stock Information
  • Founded
  • ALTI 2020
  • ESPR 2008
  • Country
  • ALTI United States
  • ESPR United States
  • Employees
  • ALTI N/A
  • ESPR N/A
  • Industry
  • ALTI Investment Managers
  • ESPR Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALTI Finance
  • ESPR Health Care
  • Exchange
  • ALTI Nasdaq
  • ESPR Nasdaq
  • Market Cap
  • ALTI 283.9M
  • ESPR 305.0M
  • IPO Year
  • ALTI N/A
  • ESPR 2013
  • Fundamental
  • Price
  • ALTI $2.90
  • ESPR $1.61
  • Analyst Decision
  • ALTI
  • ESPR Buy
  • Analyst Count
  • ALTI 0
  • ESPR 7
  • Target Price
  • ALTI N/A
  • ESPR $6.36
  • AVG Volume (30 Days)
  • ALTI 127.1K
  • ESPR 4.2M
  • Earning Date
  • ALTI 03-13-2025
  • ESPR 03-04-2025
  • Dividend Yield
  • ALTI N/A
  • ESPR N/A
  • EPS Growth
  • ALTI N/A
  • ESPR N/A
  • EPS
  • ALTI N/A
  • ESPR N/A
  • Revenue
  • ALTI $206,935,000.00
  • ESPR $332,314,000.00
  • Revenue This Year
  • ALTI $25.79
  • ESPR $5.51
  • Revenue Next Year
  • ALTI $9.88
  • ESPR $1.42
  • P/E Ratio
  • ALTI N/A
  • ESPR N/A
  • Revenue Growth
  • ALTI N/A
  • ESPR 185.66
  • 52 Week Low
  • ALTI $2.33
  • ESPR $1.47
  • 52 Week High
  • ALTI $6.36
  • ESPR $3.94
  • Technical
  • Relative Strength Index (RSI)
  • ALTI 37.64
  • ESPR 48.04
  • Support Level
  • ALTI $2.33
  • ESPR $1.47
  • Resistance Level
  • ALTI $3.64
  • ESPR $1.61
  • Average True Range (ATR)
  • ALTI 0.33
  • ESPR 0.13
  • MACD
  • ALTI -0.03
  • ESPR 0.01
  • Stochastic Oscillator
  • ALTI 43.51
  • ESPR 51.28

About ALTI AlTi Global Inc.

AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments that includes Wealth Management and Strategic Alternatives. Wealth Management includes providing holistic solutions for their wealth management clients through their comprehensive range of wealth management services, including investment management and advisory services. Strategic Alternatives segment, it assists their investors with alternative investments and co-investments by providing access to highly differentiated opportunities in these areas.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Share on Social Networks: